
Keywords: AE; adverse event; ALL; acute lymphoblastic leukemia; alloSCT; allogeneic hematopoietic stem cell transplant; AYA; adolescent and young adult; BFM; Berlin-Frankfurt-Münster; CAR-T; chimeric antigen receptor-modified T cell; CCyR; complete cytogenetic r